Cargando…

Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways

Detalles Bibliográficos
Autores principales:	Zhang, Xu, Wang, Jie, Wang, Yifeng, Liu, Guanzheng, Li, Huan, Yu, Jiefeng, Wu, Runqiu, Liang, Jun, Yu, Rutong, Liu, Xuejiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074389/ https://www.ncbi.nlm.nih.gov/pubmed/35530328 http://dx.doi.org/10.3389/fonc.2022.911817

Ejemplares similares

MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
por: Zhang, Xu, et al.
Publicado: (2021)

GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death
por: Liu, Guanzheng, et al.
Publicado: (2021)

Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma
por: Liu, Guanzheng, et al.
Publicado: (2021)

Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway
por: Liu, Xuejiao, et al.
Publicado: (2020)

GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma
por: Zhang, Xu, et al.
Publicado: (2022)

SWAP-70 promotes glioblastoma cellular migration and invasion by regulating the expression of CD44s
por: Shi, Lin, et al.
Publicado: (2019)

MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
por: Joshi, Kaushal, et al.
Publicado: (2013)

MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR‐induced NF‐κB activation
por: Liu, Xuejiao, et al.
Publicado: (2020)

Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
por: Bollu, Lakshmi Reddy, et al.
Publicado: (2020)

FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML
por: Chesnokov, Mikhail S, et al.
Publicado: (2021)

The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma
por: Liu, Xuejiao, et al.
Publicado: (2019)

UBA1 inhibition contributes radiosensitization of glioblastoma cells via blocking DNA damage repair
por: Wu, Changyong, et al.
Publicado: (2023)

circMELK promotes glioblastoma multiforme cell tumorigenesis through the miR-593/EphB2 axis
por: Zhou, Fengqi, et al.
Publicado: (2021)

EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXM1-Dependent Manner
por: Kim, Sung-Hak, et al.
Publicado: (2015)

CircPIK3C2A Facilitates the Progression of Glioblastoma via Targeting miR-877-5p/FOXM1 Axis
por: Yang, Jian, et al.
Publicado: (2021)

FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c
por: Lam, Andy K. Y., et al.
Publicado: (2013)

Corrigendum: Decreased DUSP26 Expression Promotes Malignant Behavior in Glioblastoma Cells via Deregulation of MAPK and Akt Signaling Pathway
por: Chen, Jiajia, et al.
Publicado: (2021)

PCDHB17P/miR-145-3p/MELK/NF-κB Feedback Loop Promotes Metastasis and Angiogenesis of Breast Cancer
por: Zhu, Li, et al.
Publicado: (2021)

Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1
por: Nandi, Deeptashree, et al.
Publicado: (2021)

FOXM1 is regulated by DEPDC1 to facilitate development and metastasis of oral squamous cell carcinoma
por: Qiu, Jing, et al.
Publicado: (2022)

Upregulated MELK Leads to Doxorubicin Chemoresistance and M2 Macrophage Polarization via the miR-34a/JAK2/STAT3 Pathway in Uterine Leiomyosarcoma
por: Zhang, Zhiwei, et al.
Publicado: (2020)

Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1
por: Donovan, Johnny, et al.
Publicado: (2023)

Corrigendum: Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression
por: Zhang, Ding, et al.
Publicado: (2022)

A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1
por: Shim, Jin-Kyoung, et al.
Publicado: (2022)

FOXM1 Promotes Head and Neck Squamous Cell Carcinoma via Activation of the Linc-ROR/LMO4/AKT/PI3K Axis
por: Ma, Xiao, et al.
Publicado: (2021)

CK-3, A Novel Methsulfonyl Pyridine Derivative, Suppresses Hepatocellular Carcinoma Proliferation and Invasion by Blocking the PI3K/AKT/mTOR and MAPK/ERK Pathways
por: Wu, Qiong, et al.
Publicado: (2021)

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
por: Huang, Shan-Zhou, et al.
Publicado: (2019)

FOXM1 coming of age: time for translation into clinical benefits?
por: Teh, Muy-Teck
Publicado: (2012)

FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
por: Kalathil, Dhanya, et al.
Publicado: (2021)

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2020)

xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade
por: Tang, Bufu, et al.
Publicado: (2022)

FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma
por: Luo, Weiren, et al.
Publicado: (2018)

Corrigendum: PHF20 promotes glioblastoma cell malignancies through a WISP1/BGN-dependent pathway
por: Ma, Qianquan, et al.
Publicado: (2023)

Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1
por: Zhao, Chen, et al.
Publicado: (2021)

BYSL Promotes Glioblastoma Cell Migration, Invasion, and Mesenchymal Transition Through the GSK-3β/β-Catenin Signaling Pathway
por: Sha, Zhuang, et al.
Publicado: (2020)

Akt Inhibition Enhanced the Growth Inhibition Effects of Low-Dose Heavy-Ion Radiation via the PI3K/Akt/p53 Signaling Pathway in C6 Glioblastoma Cells
por: Huang, Ke, et al.
Publicado: (2021)

The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma
por: Ma, Qing, et al.
Publicado: (2017)

Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK
por: Gong, Xianling, et al.
Publicado: (2018)

MELK is a novel therapeutic target in high-risk neuroblastoma
por: Guan, Shan, et al.
Publicado: (2017)

Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
por: Gao, Yunshu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b0ao3o2hc7goi9a4o20f60t6um